These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9915032)

  • 21. Factors associated with hepatitis B virus immunization coverage at the beginning of a population campaign in the Lazio region, Italy.
    Faustini A; Spadea T; Fano V; Giorgi Rossi P; Sangalli M; Franco E; Perucci CA
    Prev Med; 2001 Nov; 33(5):409-14. PubMed ID: 11676581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination.
    Perz JF; Elm JL; Fiore AE; Huggler JI; Kuhnert WL; Effler PV
    Pediatrics; 2006 Oct; 118(4):1403-8. PubMed ID: 17015529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006.
    Jain N; Hennessey K
    J Adolesc Health; 2009 Jun; 44(6):561-7. PubMed ID: 19465320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.
    Chang MH
    Clin Liver Dis; 2010 Aug; 14(3):521-30. PubMed ID: 20638029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Garcia D; Porras A; Rico Mendoza A; Alvis N; Navas MC; De La Hoz F; De Neira M; Osorio E; Valderrama JF
    Vaccine; 2018 May; 36(19):2721-2726. PubMed ID: 29609968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993-2014).
    Tosti ME; Alfonsi V; Lacorte E; Mele A; Galli C; Zanetti AR; Romanò L;
    Clin Infect Dis; 2016 Jun; 62(11):1412-8. PubMed ID: 27009250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of the Viral Hepatitis Prevention Board--VHPB.
    McCloy E; Meheus A
    Vaccine; 1998 Nov; 16 Suppl():S7-10. PubMed ID: 9915025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B vaccination of adolescent and adult high-risk groups in the United States.
    Mast EE; Williams IT; Alter MJ; Margolis HS
    Vaccine; 1998 Nov; 16 Suppl():S27-9. PubMed ID: 9915029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
    Wen WH; Chen HL; Ni YH; Hsu HY; Kao JH; Hu FC; Chang MH
    Hepatology; 2011 Feb; 53(2):429-36. PubMed ID: 21274864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field.
    Da Villa G; Picciottoc L; Elia S; Peluso F; Montanaro F; Maisto T
    Vaccine; 1995 Sep; 13(13):1240-3. PubMed ID: 8578810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cohesive European policy for hepatitis B vaccination, are we there yet?
    Lernout T; Hendrickx G; Vorsters A; Mosina L; Emiroglu N; Van Damme P
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():19-24. PubMed ID: 24829936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
    Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
    MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale for the infant and adolescent vaccination programmes in Italy.
    Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S31-4. PubMed ID: 10683541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National infrastructures for delivery of hepatitis B vaccination to different age groups.
    Bühlmann U
    Vaccine; 1995; 13 Suppl 1():S52-3. PubMed ID: 7571832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.